HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lonchampt, M. Articles by Duhault, J. Search for Related Content PubMed PubMed Citation Articles by Lonchampt, M. Articles by Duhault, J.

Hyperoxia/Normoxia-Driven Retinal Angiogenesis in Mice: A Role for Angiotensin II

From the Division of Diabetes and Metabolic Diseases, Institut de Recherches Servier, Suresnes, France.

PURPOSE. To examine a possible role for the angiotensin system in a rodent model of retinopathy of prematurity.

METHODS. A previously described model was used in which oxygen cycling (5 days hyperoxia and 5 days hypoxia) induced retinal alterations in newborn mice. An angiotensin-converting enzyme inhibitor (perindopril), or angiotensin receptor antagonists AT1 (losartan) or AT2 (PD123319) were administered subcutaneously for 5 days after the hyperoxia exposure. According to histologic methods, the endothelial cell count within the anterior part of the ganglion cell layer was used for the evaluation of the compound effect.

RESULTS. Histologic evaluation showed an increased number of endothelial cells in retinas of hypoxic pups compared with hyperoxic or normoxic pups. Hypoxic animals treated with perindopril (4 mg/kg) showed a significant decrease (29%, P 0.001) in endothelial cell number (163 ± 7) compared with hypoxic control animals (231 ± 10). Losartan also decreased the endothelial cell number (14%, P 0.05), whereas the AT2 antagonist had no effect.

CONCLUSIONS. The data showed a protective effect of an angiotensin-converting enzyme inhibitor and of an AT1 receptor antagonist on hyperoxia- and normoxia-induced neovascularization in newborn mice. The results suggest a role for the angiotensin system in this model and that such compounds may be of interest in the prevention of proliferative retinopathies such as proliferative diabetic retinopathy.

This article has been cited by other articles:

				M. M. de Resende and A. S. Greene Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2814 - H2821. [Abstract] [Full Text] [PDF]

				N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al. Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2321 - 2326. [Abstract] [Full Text] [PDF]

				S. Sarlos and J. L. Wilkinson-Berka The Renin-Angiotensin System and the Developing Retinal Vasculature Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1069 - 1077. [Abstract] [Full Text] [PDF]

				N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, et al. Selective Suppression of Pathologic, but Not Physiologic, Retinal Neovascularization by Blocking the Angiotensin II Type 1 Receptor Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1078 - 1084. [Abstract] [Full Text] [PDF]

				S. Sarlos, B. Rizkalla, C. J. Moravski, Z. Cao, M. E. Cooper, and J. L. Wilkinson-Berka Retinal Angiogenesis Is Mediated by an Interaction between the Angiotensin Type 2 Receptor, VEGF, and Angiopoietin Am. J. Pathol., September 1, 2003; 163(3): 879 - 887. [Abstract] [Full Text] [PDF]

				C. J. Moravski, S. L. Skinner, A. J. Stubbs, S. Sarlos, D. J. Kelly, M. E. Cooper, R. E. Gilbert, and J. L. Wilkinson-Berka The Renin-Angiotensin System Influences Ocular Endothelial Cell Proliferation in Diabetes: Transgenic and Interventional Studies Am. J. Pathol., January 1, 2003; 162(1): 151 - 160. [Abstract] [Full Text] [PDF]

				F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174. [Abstract] [Full Text] [PDF]

				H Funatsu, H Yamashita, Y Nakanishi, and S Hori Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy Br. J. Ophthalmol., March 1, 2002; 86(3): 311 - 315. [Abstract] [Full Text] [PDF]

				J. A. Nadal, G. M. Scicli, L. A. Carbini, and A. G. Scicli Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H739 - H748. [Abstract] [Full Text] [PDF]

				R. P. Mino, P. E. Spoerri, S. Caballero, D. Player, L. Belardinelli, I. Biaggioni, and M. B. Grant Adenosine Receptor Antagonists and Retinal Neovascularization in Vivo Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3320 - 3324. [Abstract] [Full Text] [PDF]

				S. Takeshita, H. Tomiyama, N. Yokoyama, Y. Kawamura, T. Furukawa, Y. Ishigai, T. Shibano, T. Isshiki, and T. Sato Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats Cardiovasc Res, November 1, 2001; 52(2): 314 - 320. [Abstract] [Full Text] [PDF]